New Delhi: Early tests of the vaccine developed by Oxford University show a promising sign of effectiveness of the medicine. During the phase of animal trials, the vaccine showed positive results to the tests conducted by a laboratory in northwestern United States.
Six macaque monkeys were given the vaccine developed by Oxford University and were exposed to large quantities of coronavirus at the National Institutes of Health’s Rocky Mountain Laboratory in Montana in March 2020. Six other monkeys without any vaccine were also exposed to the virus.
All the six monkeys that were administered with the vaccine remained healthy after more than 28 days of being exposed to large quantities of coronavirus and also didn’t show any symptoms of the disease, as per the reports cited by researcher Vincent Munster.
The human trials of the vaccine began on April but it’s still uncertain how the vaccine will react in humans until the completion of the trial in September. The process for developing vaccines for humans is long and having a usable product for mass distribution by September is highly unlikely.
- Meghalaya Lottery September 17: Check Future Drought Morning lottery result
- COVID-19 recoveries outpace fresh cases in Arunachal
- PM Modi turns 71; dignitaries, politicians extend wishes
- India records 34,403 COVID-19 cases, 320 deaths
- Dalai Lama greets PM Modi on his birthday
- India hands over newly-constructed school building to Nepal